| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d47cce569a38aa50ad96f8ff178958b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5a10dc651e733b8d5a1ec5684b812362 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5254
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24134
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24122 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12 |
| filingDate |
2006-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f84b971ea038f9b1a2cb8597dac93f88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_367581eaf4b351084c1e0ea20e13a97d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e1b7959228db7f1673b6ae4749867c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6890738ec61bfe8c7b488fde0c2d5d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95c336ede0e148be81c62a0526cf2aac |
| publicationDate |
2008-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20080018271-A |
| titleOfInvention |
Attenuated Dengue Serotype 2 Strain |
| abstract |
The present invention relates to attenuated novel Vero-Derived Dengue serotype 2 virus (VDV2) live strain derived from wild-type Dengue-2 strain 16681 by passage in PDK cells and Vero cells. The invention also relates to a vaccine composition comprising the VDV2 strain. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11464815-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160002780-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11590221-B2 |
| priorityDate |
2005-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |